spacer
home > pmps > autumn 2008 > lean machine
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lean Machine

Pharmaceutical manufacturing costs the industry approximately $90 billion each year and represents twice the expenditure of R&D (1). A 2001 study conducted by the MIT Pharmaceutical Manufacturing Initiative (PHARMI) indicated that significant time was spent conducting quality control (QC) testing and documenting QC results during the manufacturing process (2). Eroding profit margins from stiff competition, increasing product defects, and the FDA’s focus on a ‘quality by design model’ has led the industry to reevaluate manufacturing efficiency (1,3). The industry has recently begun adopting both lean manufacturing and Six Sigma to achieve the efficiency and quality gains achieved by other industries (4-6). IT solutions will play a significant role in managing QC standard operating procedure (SOP) documentation during the focus on lean and Six Sigma to eliminate waste, improve...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Chris Stumpf joined Waters in 2001 after earning his PhD in Analytical Chemistry and Mass Spectrometry from Purdue University in 2000, and held a post doctoral position at the University of Cincinnati Medical School conducting proteomics research. During his doctorate and post-doctorate education, he became keenly interested in informatics solutions to manage and mine analytical data.

Phil Kilby joined Waters in 1998. He received a degree in Chemistry from Greenwich University while working in drug metabolism at Rhone Poulenc in London. He is now responsible for worldwide business and partnership development of Waters’ suite of informatics solutions. Email: phil_kilby@waters.com

spacer
Chris Stumpf
spacer
spacer
spacer
Phil Kilby
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers
 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement